CONDENSED BALANCE SHEETS - USD ($)	Dec. 31, 2022	Sep. 30, 2022
Current assets:
Cash and cash equivalents	$ 18,017,319	$ 22,672,138
Prepaid expenses	538,291	762,063
Supplies used for R&D and manufacturing	1,848,720	2,001,715
Total current assets	20,404,330	25,435,916
Finance lease right of use assets	10,486,344	10,937,797
Operating lease right of use assets	1,839,418	1,884,464
Property and equipment, net	11,520,968	11,889,029
Patent costs, net	202,070	212,201
Supplies used for R&D and manufacturing	104,607	164,299
Total assets	44,557,737	50,523,706
Current liabilities:
Accounts payable	1,599,812	1,618,290
Accrued expenses	800,838	842,492
Due to employees	550,575	471,488
Lease liabilities, current portion	1,790,716	1,731,481
Total current liabilities	4,741,941	4,663,751
Finance lease obligations, net of current portion	11,295,512	11,721,368
Operating lease obligations, net of current portion	1,803,663	1,850,380
Other liabilities	125,000	125,000
Total liabilities	17,966,116	18,360,499
STOCKHOLDERS' EQUITY
Preferred stock, $.01 par value-200,000 shares authorized; -0- shares issued and outstanding	0	0
Common stock, $.01 par value - 600,000,000 shares authorized; 43,725,636 and 43,448,317 shares issued and outstanding at December 31, 2022 and September 30, 2022, respectively	437,256	434,484
Additional paid-in capital	488,904,967	486,625,816
Accumulated deficit	(462,750,602)	(454,897,093)
Total stockholders' equity	26,591,621	32,163,207
TOTAL LIABILITIES AND STOCKHOLDERS' EQUITY	$ 44,557,737	$ 50,523,706